• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌根除治疗

Eradication therapy for Helicobacter pylori.

作者信息

Vakil Nimish, Megraud Francis

机构信息

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

出版信息

Gastroenterology. 2007 Sep;133(3):985-1001. doi: 10.1053/j.gastro.2007.07.008.

DOI:10.1053/j.gastro.2007.07.008
PMID:17854602
Abstract

Eradication therapy for Helicobacter pylori is recommended in a number of clinical conditions. In this article, we discuss the epidemiology and cellular mechanisms that result in antimicrobial resistance, the results of current eradication therapies, and new approaches to the management of Helicobacter pylori infection.

摘要

在多种临床情况下,推荐进行幽门螺杆菌根除治疗。在本文中,我们讨论了导致抗菌药物耐药性的流行病学和细胞机制、当前根除治疗的结果以及幽门螺杆菌感染管理的新方法。

相似文献

1
Eradication therapy for Helicobacter pylori.幽门螺杆菌根除治疗
Gastroenterology. 2007 Sep;133(3):985-1001. doi: 10.1053/j.gastro.2007.07.008.
2
Treatment of Helicobacter pylori.幽门螺杆菌的治疗。
Helicobacter. 2007 Oct;12 Suppl 1:31-7. doi: 10.1111/j.1523-5378.2007.00538.x.
3
[Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].[提高幽门螺杆菌根除方案疗效及安全性的方法]
Eksp Klin Gastroenterol. 2006(4):59-66.
4
What is the most effective regimen for eradication of Helicobacter pylori in patients who have failed a first eradication attempt?对于首次根除幽门螺杆菌尝试失败的患者,最有效的根除方案是什么?
J Fam Pract. 2002 Jan;51(1):14.
5
[Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].幽门螺杆菌相关疾病的根除治疗:疗效、安全性、药物经济学
Eksp Klin Gastroenterol. 2005(2):95-9.
6
[Leaving Helicobacter pylori no chance. Triple therapy should consider resistance status].不给幽门螺杆菌任何机会。三联疗法应考虑耐药情况
MMW Fortschr Med. 2005 May 19;147(20):52.
7
[Therapeutics of infection by Helicobacter pylori in 2008].《2008年幽门螺杆菌感染的治疗方法》
Rev Gastroenterol Mex. 2008;73(2):93-105.
8
Helicobacter pylori infection in pediatrics.小儿幽门螺杆菌感染
Helicobacter. 2007 Oct;12 Suppl 1:38-44. doi: 10.1111/j.1523-5378.2007.00532.x.
9
Treatment of Helicobacter pylori infection.幽门螺杆菌感染的治疗。
Helicobacter. 2009 Sep;14 Suppl 1:46-51. doi: 10.1111/j.1523-5378.2009.00704.x.
10
How effective are rescue H. pylori eradication therapies in patients with dyspepsia?补救性幽门螺杆菌根除疗法对消化不良患者的疗效如何?
Nat Clin Pract Gastroenterol Hepatol. 2005 Apr;2(4):180-1. doi: 10.1038/ncpgasthep0145.

引用本文的文献

1
resistance in Hainan Province, China: investigating phenotypes and genotypes through whole-genome sequencing.中国海南省的耐药性:通过全基因组测序研究表型和基因型。
Front Cell Infect Microbiol. 2024 Dec 17;14:1505166. doi: 10.3389/fcimb.2024.1505166. eCollection 2024.
2
Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Infection.预测感染一线治疗中联合疗法根除失败的独立危险因素。
Microorganisms. 2023 Dec 19;12(1):6. doi: 10.3390/microorganisms12010006.
3
Treatment of infection and gastric ulcer: Need for novel Pharmaceutical formulation.
感染与胃溃疡的治疗:新型药物制剂的需求
Heliyon. 2023 Sep 24;9(10):e20406. doi: 10.1016/j.heliyon.2023.e20406. eCollection 2023 Oct.
4
Update on the second-line treatment of infection: a narrative review.感染二线治疗的最新进展:一篇叙述性综述。
Therap Adv Gastroenterol. 2023 Sep 4;16:17562848231192750. doi: 10.1177/17562848231192750. eCollection 2023.
5
Rescue therapy for refractory infection: current status and future concepts.难治性感染的挽救治疗:现状与未来概念
Therap Adv Gastroenterol. 2023 May 6;16:17562848231170941. doi: 10.1177/17562848231170941. eCollection 2023.
6
The Roles of Innate Lymphoid Cells in the Gastric Mucosal Immunology and Oncogenesis of Gastric Cancer.固有淋巴细胞在胃癌胃黏膜免疫和发生中的作用。
Int J Mol Sci. 2023 Apr 2;24(7):6652. doi: 10.3390/ijms24076652.
7
IgY antibodies: The promising potential to overcome antibiotic resistance.IgY 抗体:克服抗生素耐药性的有前途的潜力。
Front Immunol. 2023 Jan 20;14:1065353. doi: 10.3389/fimmu.2023.1065353. eCollection 2023.
8
Update on the first-line treatment of infection in areas with high and low clarithromycin resistances.克拉霉素高耐药和低耐药地区感染一线治疗的最新进展。
Therap Adv Gastroenterol. 2022 Nov 22;15:17562848221138168. doi: 10.1177/17562848221138168. eCollection 2022.
9
Effect of Statins on Eradication Rate: A Systematic Review and Meta-Analysis.他汀类药物对根除率的影响:一项系统评价和荟萃分析。
GE Port J Gastroenterol. 2021 Sep 6;29(5):322-330. doi: 10.1159/000518597. eCollection 2022 Sep.
10
Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori.亚麻木酸-甲硝唑:一种缓解耐药性并抑制幽门螺杆菌的复方药物。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0007322. doi: 10.1128/aac.00073-22. Epub 2022 Jun 27.